Mae Galang: Apply for the Position of Rare Blood Disorder Account and Community Manager
Mae Galang, Talent Acquisition Partner at Genentech, shared a post on LinkedIn:
“We are looking for individuals with a background in hemophilia or bleeding disorders who are prepared to make a real impact.
Consider applying for the position of Rare Blood Disorder Account and Community Manager (RBD-ACM) – South Dakota/Nebraska/Iowa Ecosystem.
For more details, visit.”
Anna Becklund, Healthcare Director of Rare Diseases at Genentech, reposted Mae Galang’s post on LinkedIn:
“We’re looking for passionate, collaborative talent in Iowa, Nebraska, or South Dakota to join my Rare Blood Disorders team.
This dynamic role offers the opportunity to own the business end-to-end while partnering closely with HTCs, SPs, advocacy partners, and patients across the region to make meaningful impact in the bleeding disorders community.
Come join the Genentech family — an incredible place to grow, lead, and make a difference.”
Stay updated with Hemostasis Today.
-
Aug 31, 2026, 14:32Mahir Khalil Ibrahim Jallo: Hot Topic From The ESC 2026 Munich
-
Aug 31, 2026, 14:28Ruben Mesa: FDA Approves Ropeginterferon Alfa-2b for Essential Thrombocythemia
-
Aug 31, 2026, 14:28Francisco Chacón-Lozsán: Should We Anticoagulate AF Patients With Only One Non-Sex Stroke Risk Factor?
-
Aug 31, 2026, 14:24Akl Fahed: Do Lifelong Differences in LDL Cholesterol Influence the Risk of Venous Thromboembolism?
-
Aug 31, 2026, 14:23Accelerating CAR-T Access Through Policy and System Reform – American Society of Hematology
-
Aug 31, 2026, 14:21Shirya Rashid: Does Bempedoic Acid Influence Venous Thromboembolism Risk?
-
Aug 31, 2026, 14:14Jason Andrade: SINGLE-AF Trial Validates Early Anticoagulation in AF
-
Aug 31, 2026, 14:12Leonardo Roever: Diagnosis and Management of Natural Anticoagulant Deficiencies
-
Aug 31, 2026, 14:07Ben Dowsing: Can Heart Failure Therapy Be Safely Withdrawn After HER2 Cardiotoxicity Recovery